MERCK, S.A. secures contract for Pharmaceutical products - C/ BASE NO CPA 2026_6 - CABOZANTINIB 20 MG COMP TEPOTINIB 225 MG COMP

Portugal, Oct. 28 -- Portugal based MERCK, S.A. has secured contract from Unidade Local de Saude de Coimbra, EPE for Pharmaceutical products - C/ BASE NO CPA 2026_6 - CABOZANTINIB 20 MG COMP TEPOTINIB 225 MG COMP. The value of the contract is worth 170679.96 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....